bifeprunox has been researched along with olanzapine in 3 studies
Studies (bifeprunox) | Trials (bifeprunox) | Recent Studies (post-2010) (bifeprunox) | Studies (olanzapine) | Trials (olanzapine) | Recent Studies (post-2010) (olanzapine) |
---|---|---|---|---|---|
30 | 1 | 12 | 6,339 | 1,340 | 2,383 |
Protein | Taxonomy | bifeprunox (IC50) | olanzapine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.097 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.155 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.047 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.04 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.541 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.768 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.118 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.047 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.421 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.531 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.392 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.072 | |
D(4) dopamine receptor | Homo sapiens (human) | 0.173 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.092 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.038 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.021 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.047 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.033 | |
Histamine H1 receptor | Homo sapiens (human) | 0.013 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.078 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.057 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.013 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.158 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2028 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pettersson, F; Pontén, H; Sonesson, C; Waters, N; Waters, S | 1 |
Aliaga, M; Assié, MB; Barbara, M; Bardin, L; Carilla-Durand, E; Malfètes, N; Maraval, M; Newman-Tancredi, A | 1 |
Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
3 other study(ies) available for bifeprunox and olanzapine
Article | Year |
---|---|
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Cell Line; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Ligands; Male; Models, Chemical; Molecular Structure; Motor Activity; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benzofurans; Benzoxazoles; Benzylamines; Blood Glucose; Clozapine; Corticosterone; Cyclopentanes; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Thiazoles | 2008 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |